Animal studies have shown that periodontitis is associated with local microbiologically induced complement activation (18, 19), and therapeutic inhibition of C3 has been suggested as promising therapeutic options for periodontitis which has already entered clinical trials (20, 21). This evidence concerns the gene C3 and periodontitis.